Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Sun Pharma"
Count: 91
Selected: 0
NCT IDTitle
NCT04942054A Study in Patients With Advanced Breast Cancer
NCT04242953Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects
NCT02629692Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment Refractory/Intolerant CML Failing ≥3 Prior CML Therapies
NCT03655236PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706
NCT03450629Evaluation of Safety and Efficacy of PDP-716
NCT03055143Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer
NCT03426267Evaluation of Efficacy and Safety of SDN-037
NCT00947661Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension
NCT00945958Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension
NCT02597465A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507
NCT04332549To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer
NCT02970019Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease
NCT03445338To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers
NCT01457352Efficacy and Safety of SPARC0921 in Subjects With Spasticity
NCT03316820Bioavailability Study of K0706 in Healthy Subjects
NCT03109249Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer
NCT02991261Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers
NCT02991222Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers
NCT02887534Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain
NCT02618395Bioavailability Study of SPARC001 in Healthy Adult Volunteers
NCT02136927Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer
NCT02027025Study of SPARC1103 in Subjects With Spasticity
NCT01940146Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis
NCT01797185Safety Study of SPARC1104
NCT01614691Safety and Efficacy of SPARC1203 in Allergic Rhinitis
NCT01305512Pharmacokinetic, Safety and Tolerability Study of SPARC1028
NCT01304303Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination
NCT00863174A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma
NCT00862355Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer
NCT03567941To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen
NCT02346058Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins
NCT01320553Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis
NCT02041221Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316
NCT03996460K0706 for Patients Diagnosed With Dementia With Lewy Bodies
NCT05374343A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment
NCT05133882A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
NCT05057949A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants
NCT05048368Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function
NCT04992858Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations
NCT04865458A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies
NCT04827069A Clinical Trial to Evaluate Clifutinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia(AML)
NCT04324372Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors
NCT04131192Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
NCT03888092Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification
NCT05127772A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing
NCT05294536A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
NCT04512170Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects
NCT05059743ADME Study of [14C]- Larotinib in Healthy Male Subjects
NCT05139719Phase ll Study of HEC585 in Patients With PF-ILD
NCT05109078ADME Study of [14C]- Rongliflozin in Healthy Male Subjects